arrow
Back
M

Mark S. Cragg

university of southampton

67H-index
401Paper Count
2.1WCitation Count
Published Papers 140
Publication Date
Gas-phase unfolding assay rapidly predicts structure-function relationships in engineered antibodies with tuned flexibilities
err2026-06-29
err0
errOAAI
errRosendo C. Villafuerte-Vega; Michael R. Armbruster; Hayden Fisher; Isabel G. Elliott; H. T. Claude Chan; Tatyana Inzhelevskaya; C. Ian Mockridge; Christine A. Penfold; Patrick J. Duriez; Mark S. Cragg; Brandon T. Ruotolo
errShare
errSave
Realizing the potential of agonistic antibody immunotherapy
err2026-05-19
err0
PREAI
errMark S. Cragg; Xiaojie Yu; Christopher Paluch; Simon J. Davis
errShare
errSave
Structure-guided disulfide engineering restricts antibody conformation to elicit TNFR agonism
err2025-04-12
err0
errOAAI
errElliott, Isabel G.; Fisher, Hayden; Chan, H. T. Claude; Inzhelevskaya, Tatyana; Mockridge, C. Ian; Penfold, Christine A.; Duriez, Patrick J.; Orr, Christian M.; Herniman, Julie; Muller, Kri T. J.; Essex, Jonathan W.; Cragg, Mark S.; Tews, Ivo
errShare
errSave
FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs
err2025-03-16
err0
errOAAI
errSimpson, Alexander P.; Oldham, Robert J.; Cox, Kerry L.; Taylor, Martin C.; James, Sonya; White, Ann L.; Bogdanov, Yury; Glennie, Martin J.; Frendeus, Bjoern; Cragg, Mark S.; Roghanian, Ali
errShare
errSave
Therapeutic targeting of tumour-associated macrophage receptors
err2025-03-11
err0
errOAAI
errMartins, Rosa Gomes Alves; Tekin, Mehmet M.; Cragg, Mark S.; Roghanian, Ali
errShare
errSave
The ETS-family transcription factor PU.1 is a critical regulator of the inhibitory Fcγ receptor IIB expression in humans
err2025-02-26
err0
errOAAI
errCarter, Matthew J.; Bogdanov, Yury D.; Smith, Rosanna C.; Cox, Kerry L.; Frampton, Sarah; Ferson, Lili; Foxall, Russel B.; Hussain, Khiyam; Strefford, Jonathan C.; Beers, Stephen A.; Cragg, Mark S.
errShare
errSave
CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis
err2025-01-01
err0
errOAAI
errGraham, Lara, V; Horehajova, Ludmila; Haselager, Marco, V; Fisher, Jack G.; Roos, Jamie Lee; Foxall, Russell B.; John, Mel; Cox, Kerry L.; Oldham, Robert J.; Taylor, Martin C.; Ashton-Key, Margaret; Sale, Ben; Bartlett, Laura G.; Roghanian, Ali; Eldering, Eric; Vallejo, Andres F.; Forconi, Francesco; Khakoo, Salim, I; Cragg, Mark S.; Blunt, Matthew D.
errShare
errSave
Downhill running does not alter blood C1q availability or complement-dependent cytotoxicity of therapeutic monoclonal antibodies against haematological cancer cell lines in vitro
err2024-11-15
err0
errOAAI
errCollier-Bain, Harrison D.; Brown, Frankie F.; Causer, Adam J.; Ross, Lois; Rothschild-Rodriguez, Daniela; Browne, Noah; Eddy, Rachel; Cleary, Kirstie L.; Gray, Juliet C.; Cragg, Mark S.; Moore, Sally; Murray, James; Turner, James E.; Campbell, John P.
errShare
errSave
Fc gamma receptors: Their evolution, genomic architecture, genetic variation, and impact on human disease
err2024-09-30
err0
errOAAI
errFrampton, Sarah; Smith, Rosanna; Ferson, Lili; Gibson, Jane; Hollox, Edward J.; Cragg, Mark S.; Strefford, Jonathan C.
errShare
errSave
KIR2DS2+NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies
err2024-09-02
err0
errOAAI
errGraham, Lara V.; Fisher, Jack G.; Doyle, Amber D. P.; Sale, Ben; Del Rio, Luis; French, Albert J. E.; Mayor, Neema P.; Turner, Thomas R.; Marsh, Steven G. E.; Cragg, Mark S.; Forconi, Francesco; Khakoo, Salim I.; Blunt, Matthew D.
errShare
errSave
Cross-talk between ILC2 and Gata3high Tregs locally constrains adaptive type 2 immunity
err2024-07-19
err0
errOAAI
errStockis, Julie; Yip, Thomas; Moreno-Vicente, Julia; Burton, Oliver; Samarakoon, Youhani; Schuijs, Martijn J.; Raghunathan, Shwetha; Garcia, Celine; Luo, Weike; Whiteside, Sarah K.; Png, Shaun; Simpson, Charlotte; Monk, Stela; Sawle, Ashley; Yin, Kelvin; Barbieri, Johanna; Papadopoulos, Panagiotis; Wong, Hannah; Rodewald, Hans-Reimer; Vyse, Timothy; McKenzie, Andrew N. J.; Cragg, Mark S.; Hoare, Matthew; Withers, David R.; Fehling, Hans Joerg; Roychoudhuri, Rahul; Liston, Adrian; Halim, Timotheus Y. F.
errShare
errSave
Impact of isotype on the mechanism of action of agonist anti-OX40 antibodies in cancer: implications for therapeutic combinations
err2024-07-04
err0
errOAAI
errWilloughby, Jane E.; Dou, Lang; Bhattacharya, Sabyasachi; Jackson, Heather; Seestaller-Wehr, Laura; Kilian, David; Bover, Laura; Voo, Kui S.; Cox, Kerry L.; Murray, Tom; John, Mel; Shi, Hong; Bojczuk, Paul; Jing, Junping; Niederer, Heather; Shepherd, Andrew J.; Hook, Laura; Hopley, Stephanie; Inzhelevskaya, Tatyana; Penfold, Chris A.; Mockridge, C. Ian; English, Vikki; Brett, Sara J.; Srinivasan, Roopa; Hopson, Christopher; Smothers, James; Hoos, Axel; Paul, Elaine; Martin, Stephen L.; Morley, Peter J.; Yanamandra, Niranjan; Cragg, Mark S.
errShare
errSave
A single bout of vigorous intensity exercise enhances the efficacy of rituximab against human chronic lymphocytic leukaemia B-cells ex vivo
err2024-05-01
err3
errOAAI
errCollier-Bain, Harrison D.; Emery, Annabelle; Causer, Adam J.; Brown, Frankie F.; Oliver, Rebecca; Dutton, David; Crowe, Josephine; Augustine, Daniel; Graby, John; Leach, Shoji; Eddy, Rachel; Rothschild-Rodriguez, Daniela; Gray, Juliet C.; Cragg, Mark S.; Cleary, Kirstie L.; Moore, Sally; Murray, James; Turner, James E.; Campbell, John P.
errShare
errSave
Disrupting B and T-cell collaboration in autoimmune disease: T-cell engagers versus CAR T-cell therapy?
err2024-04-20
err6
errOAAI
errShah, Kavina; Leandro, Maria; Cragg, Mark; Kollert, Florian; Schuler, Franz; Klein, Christian; Reddy, Venkat
errShare
errSave
MicroRNA manipulation of macrophage polarization in DLBCL to augment antibody immunotherapy
err2024-03-22
err0
PREAI
errLongley, Jemma; Foxall, Russell; Thirdborough, Steven; Beers, Steve; Cragg, Mark
errShare
errSave
Soluble CTLA-4 attenuates T cell activation and modulates anti-tumor immunity
err2024-02-01
err11
errOAAI
errKennedy, Paul T.; Saulters, Emma L.; Duckworth, Andrew D.; Lim, Yeong Jer; Woolley, John F.; Slupsky, Joseph R.; Cragg, Mark S.; Ward, Frank J.; Dahal, Lekh N.
errShare
errSave
Agonist Antibodies for Cancer Immunotherapy: History, Hopes, and Challenges
err2023-12-28
err2
errOAAI
errLim, Sean H.; Beers, Stephen A.; Al-Shamkhani, Aymen; Cragg, Mark S.
errShare
errSave
Human leukocyte immunoglobulin-like receptors in health and disease
err2023-11-13
err14
errOAAI
errRedondo-Garcia, Silvia; Barritt, Christopher; Papagregoriou, Charys; Yeboah, Muchaala; Frendeus, Bjorn; Cragg, Mark S.; Roghanian, Ali
errShare
errSave